MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome.  It offers Next-Generation Sequencing based genomic solutions in cancer immunotherapy. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level, to facilitate research in personalized health care. MedGenome is the market leader for genomic diagnostics in South Asia and a leading provider of genomics research services globally. MedGenome has its Corporate Headquarters and a CLIA certified, CAP accredited & ISO 15189 certified lab in Foster City, California, US.  MedGenome, in Bangalore, India, has the highest throughput Next-Generation Sequencing lab in South-East Asia. 

Current Investors/Backers

MedGenome is backed by Sequoia Capital.

Venture Fund Commitment

ATEL Ventures, Inc. has provided MedGenome a Growth Capital Loan.


For more information on MedGenome please visit their web site at



ATEL Portfolio News